<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">86125</article-id><article-id pub-id-type="doi">10.7554/eLife.86125</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-304403"><name><surname>Croft</surname><given-names>Wayne</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6780-5944</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304406"><name><surname>Pearce</surname><given-names>Hayden</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304407"><name><surname>Margielewska-Davies</surname><given-names>Sandra</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5115-470X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304408"><name><surname>Lim</surname><given-names>Lindsay</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1394-3297</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304409"><name><surname>Nicol</surname><given-names>Samantha M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304410"><name><surname>Zayou</surname><given-names>Fouzia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304411"><name><surname>Blakeway</surname><given-names>Daniel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9501-7451</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304412"><name><surname>Marcon</surname><given-names>Francesca</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7439-8291</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304510"><name><surname>Powell-Brett</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304516"><name><surname>Mahon</surname><given-names>Brinder</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304512"><name><surname>Merard</surname><given-names>Reena</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-192178"><name><surname>Zuo</surname><given-names>Jianmin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304513"><name><surname>Middleton</surname><given-names>Gary</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304514"><name><surname>Roberts</surname><given-names>Keith</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-304515"><name><surname>Brown</surname><given-names>Rachel M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-148122"><name><surname>Moss</surname><given-names>Paul</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6895-1967</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Institute of Immunology and Immunotherapy</institution>, <institution>University of Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Cancer Research Horizons</institution>, <institution>The Francis Crick Institute</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution>University Hospitals Birmingham NHS Foundation Trust</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-75453"><name><surname>Macleod</surname><given-names>Kay F</given-names></name><role>Reviewing editor</role><aff><institution>University of Chicago</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>p.moss@bham.ac.uk</email> (PM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>06</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e86125</elocation-id><history><date date-type="received"><day>11</day><month>01</month><year>2023</year></date><date date-type="accepted"><day>22</day><month>06</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Croft et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Croft et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-86125-v1.pdf"/><abstract><p>Pancreatic ductal adenocarcinoma has a poor clinical outcome and responses to immunotherapy are suboptimal. Stromal fibroblasts are a dominant but heterogenous population within the tumor microenvironment and therapeutic targeting of stromal subsets may have therapeutic utility. Here we combine spatial transcriptomics and scRNA-Seq datasets to define the transcriptome of tumor-proximal and tumor-distal cancer-associated fibroblasts (CAFs) and link this to clinical outcome. Tumor-proximal fibroblasts comprise large populations of myofibroblasts, strongly expressed podoplanin, and were enriched for Wnt ligand signaling. In contrast, inflammatory CAFs were dominant within tumor-distal subsets and expressed complement components and the Wnt-inhibitor SFRP2. Poor clinical outcome was correlated with elevated HIF-1a and podoplanin expression whilst expression of inflammatory and complement genes was predictive of extended survival. These findings demonstrate the extreme transcriptional heterogeneity of CAFs and its determination by apposition to tumor. Selective targeting of tumor-proximal subsets, potentially combined with HIF-1a inhibition and immune stimulation, may offer a multi-modal therapeutic approach for this disease.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>A21135</award-id><principal-award-recipient><name><surname>Croft</surname><given-names>Wayne</given-names></name><name><surname>Pearce</surname><given-names>Hayden</given-names></name><name><surname>Margielewska-Davies</surname><given-names>Sandra</given-names></name><name><surname>Lim</surname><given-names>Lindsay</given-names></name><name><surname>Nicol</surname><given-names>Samantha M</given-names></name><name><surname>Zayou</surname><given-names>Fouzia</given-names></name><name><surname>Blakeway</surname><given-names>Daniel</given-names></name><name><surname>Marcon</surname><given-names>Francesca</given-names></name><name><surname>Powell-Brett</surname><given-names>Sarah</given-names></name><name><surname>Mahon</surname><given-names>Brinder</given-names></name><name><surname>Merard</surname><given-names>Reena</given-names></name><name><surname>Zuo</surname><given-names>Jianmin</given-names></name><name><surname>Middleton</surname><given-names>Gary</given-names></name><name><surname>Roberts</surname><given-names>Keith</given-names></name><name><surname>Brown</surname><given-names>Rachel M</given-names></name><name><surname>Moss</surname><given-names>Paul</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Samples were obtained from the Birmingham Human Biomaterials Resource Centre HBRC (HTA Licence 12358) ethically approved North West - Haydock Research Ethics Committee; Ref 20/NW/0001, local ethics number 18-304.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Source Data 1 contains the raw Nanostring nCounter data.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Pearce H</collab><collab>Croft W</collab><collab>Nicol S</collab><collab>Margielewska-Davies S</collab><collab>Powell R</collab><collab>Cornall R</collab><collab>Davis SJ</collab><collab>Marcon F</collab><collab>Pugh M</collab><collab>Fennell Ã</collab><collab>Powell-Brett S</collab><collab>Brown R</collab><collab>Middleton G</collab><collab>Mahon B</collab></person-group><year iso-8601-date="2023">2023</year><source>Tissue-resident memory T-cells in pancreatic ductal adenocarcinoma co-express PD-1 and TIGIT and inhibition is reversible by dual antibody blockade</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE210199">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE210199</ext-link><comment>NCBI Gene Expression Omnibus, GSE210199</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-86125-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>